Genus plc (LON:GNS – Get Free Report) announced a dividend on Thursday, September 5th, Upcoming.Co.Uk reports. Investors of record on Thursday, November 7th will be given a dividend of GBX 21.70 ($0.29) per share on Friday, December 6th. This represents a dividend yield of 1.21%. The ex-dividend date of this dividend is Thursday, November 7th. This is a boost from Genus’s previous dividend of $10.30. The official announcement can be seen at this link.
Genus Stock Performance
Genus stock opened at GBX 1,734 ($22.80) on Friday. The stock’s 50 day moving average is GBX 1,745.44 and its 200 day moving average is GBX 1,775.64. The company has a quick ratio of 1.08, a current ratio of 2.15 and a debt-to-equity ratio of 50.99. Genus has a twelve month low of GBX 1,478 ($19.43) and a twelve month high of GBX 2,378 ($31.27). The company has a market capitalization of £1.14 billion, a P/E ratio of 3,423.53, a PEG ratio of 2.87 and a beta of 0.38.
Analyst Ratings Changes
Separately, Deutsche Bank Aktiengesellschaft cut their target price on Genus from GBX 2,300 ($30.24) to GBX 2,150 ($28.27) and set a “buy” rating on the stock in a research note on Wednesday, July 17th.
Genus Company Profile
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.
Read More
- Five stocks we like better than Genus
- The Role Economic Reports Play in a Successful Investment Strategy
- 3 Stocks to Watch as Firms Cut Costs Ahead of Potential Recession
- Earnings Per Share Calculator: How to Calculate EPS
- AST SpaceMobile: Reaching for the Stars or Overheating in Orbit?
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Who Will Come Out on Top in the Chinese Coffee Wars?
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.